SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-22-000061
Filing Date
2022-09-12
Accepted
2022-09-12 16:19:59
Documents
12
Period of Report
2022-09-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K alpn-20220912.htm   iXBRL 8-K 48143
  Complete submission text file 0001626199-22-000061.txt   191076

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20220912.xsd EX-101.SCH 1951
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20220912_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20220912_pre.xml EX-101.PRE 13082
6 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20220912_htm.xml XML 11265
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 221238775
SIC: 2834 Pharmaceutical Preparations